Suppr超能文献

适度的手术治疗延迟会影响结肠癌患者的生存吗?

Do Moderate Surgical Treatment Delays Influence Survival in Colon Cancer?

作者信息

Wanis Kerollos Nashat, Patel Sanjay V B, Brackstone Muriel

机构信息

Department of Surgery, Western University, London Health Sciences Centre, London, Ontario, Canada.

出版信息

Dis Colon Rectum. 2017 Dec;60(12):1241-1249. doi: 10.1097/DCR.0000000000000857.

Abstract

BACKGROUND

Studies examining treatment delay and survival after surgical treatment of colon cancer have varied in quality and outcome, with little evidence available regarding the safety of longer surgical treatment wait times.

OBJECTIVE

Our study examined the effect of surgical treatment wait times on survival for patients with stage I to III colon cancer.

DESIGN

A subset cohort analysis was performed using data from a prospectively maintained database.

SETTINGS

The study was conducted at a tertiary referral center.

PATIENTS

Data on all of the patients undergoing elective surgery for stage I to III colon cancer from 2006 to 2015 were collected from a prospectively maintained clinical and administrative database.

MAIN OUTCOME MEASURES

We examined the impact of prolonged wait time to surgery on disease-free and overall survival. Patients were divided into 2 groups based on a treatment wait time of ≤30 or >30 days and were compared using a Cox proportional hazards model. A subgroup analysis was performed using alternative treatment delay cutoffs of 60 and 90 days.

RESULTS

There were 908 patients with stage I to III colon cancer treated over the study period, with a median treatment wait time of 38 days (interquartile range, 21-61 days); 368 patients were treated within 30 days, and 540 were treated beyond 30 days from diagnosis. In adjusted multivariate analysis, a treatment delay of >30 days was not associated with decreased disease-free survival (HR = 0.89 (95% CI, 0.61-1.3); p = 0.52) or overall survival (HR = 0.82 (95% CI, 0.63-1.1); p = 0.16). Likewise, subgroup analysis using alternative treatment delay cutoffs of 60 and 90 days did not demonstrate an adverse effect on survival.

LIMITATIONS

This study was limited by retrospective analysis.

CONCLUSIONS

Despite longer median treatment wait times from diagnosis to surgery, with the majority of patients exceeding 30 days and many experiencing delays of 2 to 3 months, no adverse impact on survival was observed. Patients who require additional consultations or investigations preoperatively may safely have their surgery moderately delayed to minimize their perioperative risk without any evidence that this will compromise treatment outcomes. See Video Abstract at http://links.lww.com/DCR/A397.

摘要

背景

关于结肠癌手术治疗后的治疗延迟和生存率的研究在质量和结果方面存在差异,几乎没有证据表明较长的手术治疗等待时间的安全性。

目的

我们的研究探讨了手术治疗等待时间对Ⅰ至Ⅲ期结肠癌患者生存率的影响。

设计

使用前瞻性维护数据库中的数据进行亚组队列分析。

地点

该研究在一家三级转诊中心进行。

患者

从2006年至2015年,从前瞻性维护的临床和管理数据库中收集了所有接受Ⅰ至Ⅲ期结肠癌择期手术患者的数据。

主要观察指标

我们研究了延长手术等待时间对无病生存期和总生存期的影响。根据治疗等待时间≤30天或>30天将患者分为两组,并使用Cox比例风险模型进行比较。使用60天和90天的替代治疗延迟临界值进行亚组分析。

结果

在研究期间,共治疗了908例Ⅰ至Ⅲ期结肠癌患者,中位治疗等待时间为38天(四分位间距,21 - 61天);368例患者在30天内接受治疗,540例患者在诊断后30天以上接受治疗。在调整后的多变量分析中,治疗延迟>30天与无病生存期降低(风险比=0.89(95%可信区间,0.61 - 1.3);p = 0.52)或总生存期降低(风险比=0.82(95%可信区间,0.63 - 1.1);p = 0.16)无关。同样,使用60天和90天的替代治疗延迟临界值进行的亚组分析未显示对生存率有不利影响。

局限性

本研究受回顾性分析的限制。

结论

尽管从诊断到手术的中位治疗等待时间较长,大多数患者超过30天,许多患者经历2至3个月的延迟,但未观察到对生存率有不利影响。术前需要额外会诊或检查的患者可以安全地适度延迟手术,以将围手术期风险降至最低,且没有证据表明这会影响治疗结果。见视频摘要:http://links.lww.com/DCR/A397

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验